Valneva has received marketing authorisation from the Brazilian Health Regulatory Agency for its single-dose chikungunya vaccine, Ixchiq.

Vimkunya is now available in the US for the prevention of disease caused by chikungunya virus in individuals 12 years of age ...

Discover how a structural breakthrough in the chikungunya virus is opening new avenues for antiviral drug development and ...

The development of polyvalent immunoglobulins purified from human plasma samples of convalescent Chikungunya patients could benefit infected viremic mothers and newborns.

A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since clinically, symptoms resemble those of dengue fever. Laboratory diagnosis is therefore ...

People of any age can be infected with the disease. Chikungunya patients should be given water, natural drinks, and paracetamol. Medications should be given to all Chikungunya patients only according ...

the U.S. Centers for Disease Control and Prevention said the patients were all 65 and older. They were hospitalized for cardiac or neurologic symptoms following the vaccination. The Chikungunya ...

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life ...

Reunion Island faces a chikungunya outbreak with 6,000 new cases in one week. A vaccination campaign starts Monday to protect ...

(WDTN) - Five people who recently received a vaccine that prevents a disease caused by chikungunya virus have been hospitalized. On Tuesday, the U.S. Centers for Disease Control and Prevention said ...

Vimkunya is supplied as an injectable suspension; the vaccine is administered intramuscular as a single 0.8mL dose. Vimkunya ™ (chikungunya vaccine, recombinant) is now available in the US for ...